Yale Bulletin and Calendar

September 30, 2005|Volume 34, Number 5

Team identifies neurotransmitter that
halts cell overproduction in the brain

A team of researchers has identified a neurotransmitter that helps curb the overproduction of stem cells that can lead to brain tumors.

Tight regulation of new cell growth in the adult brain is critical since uncontrolled proliferation can lead to devastating diseases, such as cancer.

In a study at the School of Medicine, scientists have found that the release of the neurotransmitter GABA by adult neuronal precursor cells that develop into neurons limits stem cell proliferation. The research was reported in the September issue of Nature Neuroscience.

"The GABAergic signaling described in our paper allows a proper balance between stem cells and daughter cells and prevents out-of-control proliferation of stem cells," says Angelique Bordey, assistant professor in the Departments of Neurosurgery and Cellular & Molecular Physiology, and senior author of the study. "The next question we would like to answer is what would happen if this signaling was disrupted in a living being."

Neural stem cells in the subventricular zone of the brain are thought to give rise to glioma, or brain tumors, when their proliferation is out of control, explains Bordey.

"One of the goals of this line of research is to find ways to promote neurogenesis in a controlled manner, so identifying signaling pathways, factors and receptors that block or promote neurogenesis is very important," she says. "These factors and receptors provide additional sites for pharmaceutical targets to promote neurogenesis and self-renewal of dying cells."

Alternatively, identifying negative GABAergic signaling on stem cell proliferation, as the researchers did in this study, suggests that any drugs that would enhance GABA's function may limit neurogenesis, she says.

"GABAergic drugs such as alcohol and benzodiazepines (some sleeping pills) have been used by a large number of individuals in our society and these drugs are expected to block stem cell proliferation," Bordey says. "Such an impact of these drugs on neurogenesis and brain function would be the next step to investigate."

Co-authors of the study include Xiuxin Liu and Qin Wang of Yale and Tarik Haydar of George Washington University School of Medicine.

-- By Jacqueline Weaver

T H I SW E E K ' SS T O R I E S

Alumnus Ruebhausen bequeaths over $30 million to Law School

Treatment boosts survival from uterine cancer

Yale Workplace Survey spurring new initiatives

Results of Yale Workplace Survey

Scientists learn how an ancient zebra lost its stripes

NBA star shares his vision for health care in Africa

India's finance minister discusses links in the global economy

House designed and built by architecture students . . .

Team identifies neurotransmitter that halts cell overproduction in the brain

Saturday series for children shows them that 'science is for everyone'

Conference, exhibit celebrate bicentennial of Tocqueville's birth

Special Collections Fair will feature rare look at unique items

Neurobiologist wins Javits Award

Serge Lang, mathematician and defender of academic standards

NBC president to discuss the network's new season

Flying dinosaur

Conference to focus on new educational technologies

Year-long seminar series will explore the changing face of antisemitism

Panel on future of democracy to launch Jamestown Project

'We the People ...'

School of Drama/Yale Rep appoints two new development officers